Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Targeting inflammation to treat diabetic kidney disease: the road to 2030
Diabetic kidney disease (DKD) is one of the fastest growing causes of chronic kidney
disease and associated morbidity and mortality. Preclinical research has demonstrated the …
disease and associated morbidity and mortality. Preclinical research has demonstrated the …
[HTML][HTML] Chronic kidney disease-induced muscle atrophy: Molecular mechanisms and promising therapies
K Wang, Q Liu, M Tang, G Qi, C Qiu, Y Huang… - Biochemical …, 2023 - Elsevier
Chronic kidney disease (CKD) is a high-risk chronic catabolic disease due to its high
morbidity and mortality. CKD is accompanied by many complications, leading to a poor …
morbidity and mortality. CKD is accompanied by many complications, leading to a poor …
Chronic kidney disease: Definition, updated epidemiology, staging, and mechanisms of increased cardiovascular risk
Chronic kidney disease is defined by the presence of kidney damage or decreased kidney
function for at least three months, irrespective of the cause. 2 Kidney damage generally …
function for at least three months, irrespective of the cause. 2 Kidney damage generally …
Use of continuous glucose monitoring in the assessment and management of patients with diabetes and chronic kidney disease
In developed countries, diabetes is the leading cause of chronic kidney disease (CKD) and
accounts for 50% of incidence of end stage kidney disease. Despite declining prevalence of …
accounts for 50% of incidence of end stage kidney disease. Despite declining prevalence of …
Nutritional management in patients with chronic kidney disease: A focus on renal diet
Chronic Kidney Disease (CKD) is a significant global health issue, contributing to high rates
of morbidity and mortality. Nutritional management, particularly through the implementation …
of morbidity and mortality. Nutritional management, particularly through the implementation …
Clinical outcomes following discontinuation of renin-angiotensin-system inhibitors in patients with type 2 diabetes and advanced chronic kidney disease: a prospective …
Background Renin-angiotensin-system inhibitors (RASi), that include angiotensin converting
enzyme inhibitors (ACEis) and angiotensin receptor blockers (ARBs) reduce proteinuria …
enzyme inhibitors (ACEis) and angiotensin receptor blockers (ARBs) reduce proteinuria …
[HTML][HTML] Broadening horizons in mechanisms, management, and treatment of diabetic kidney disease
Diabetic kidney disease (DKD) is the first cause of end-stage kidney disease in patients with
diabetes and its prevalence is increasing worldwide. It encompasses histological alterations …
diabetes and its prevalence is increasing worldwide. It encompasses histological alterations …
Clinical outcomes following discontinuation of metformin in patients with type 2 diabetes and advanced chronic kidney disease in Hong Kong: a territory-wide …
Background Current labelling advises discontinuation of metformin when estimated
glomerular filtration rate (eGFR)< 30 ml/min/1.73 m 2 due to increased risk of lactic acidosis …
glomerular filtration rate (eGFR)< 30 ml/min/1.73 m 2 due to increased risk of lactic acidosis …
Association of glucagon-like peptide-1 receptor agonist vs dipeptidyl peptidase-4 inhibitor use with mortality among patients with type 2 diabetes and advanced …
Importance Glucagon-like peptide-1 (GLP-1) receptor agonist use is associated with
reduced mortality and improved cardiovascular outcomes in the general population with …
reduced mortality and improved cardiovascular outcomes in the general population with …
Effects of short-term potassium chloride supplementation in patients with CKD
Background Observational studies suggest that adequate dietary potassium intake (90–120
mmol/day) may be renoprotective, but the effects of increasing dietary potassium and the risk …
mmol/day) may be renoprotective, but the effects of increasing dietary potassium and the risk …